Cigna Stock Falls Despite Strong Q3 Revenue Growth

Cigna's stock fell over 17% despite reporting a 10% rise in Q3 revenue. Investor concern is focused on future profit pressure from new contracts and a shift to a rebate-free drug model.

By Priya Sharma